Spatial distribution and prognostic value of tumor-associated macrophages in head and neck squamous cell carcinomas
Frontiers in Oncology · 08.05.2026 · 16
DOI: 10.3389/fonc.2026.1806162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 08.05.2026. Verfasst von Miray-Su Yılmaz Topçuoğlu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, University of Heidelberg, Medical Faculty of Heidelberg, Heidelberg, Germany. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Tumor-associated macrophages (TAMs) belong to the most frequent immune cells in the tumor microenvironment of head and neck squamous cell carcinomas (HNSCC). They can undergo an anti- or pro-tumoral polarization, the latter often referred to as M2-like activation. Because existing data are either not consistent, not well-connected to clinicopathological parameters or lack a detailed spatial distribution, we aimed to get more insight into the relevance of this immune cell population and their activation status.
Methods
This study analyzed the spatial distribution and prognostic value of CD68+TAMs and CD68+CD163+M2-like TAMs in different tumor compartments and tumor-distant stromal areas, in 85 treatment-naïve HNSCC. Various clinicopathological features were considered, such as major tumor sites, stage, T-stage, nodal status and p16-status. TAM and M2-like TAM densities were analyzed using multicolor immunofluorescence stainings followed by an objective tissue cytometry-based quantification at the single-cell level in whole tissue sections and subsequent uni- and multivariate survival analyses.
Results
Whereas we observed higher TAM and M2-like TAM densities in p16-negative HNSCC specimens, densities of M2-like TAMs were highest in the tumor-near stroma of advanced nodal-positive p16-negative HNSCC compared to tumor cell nests and tumor-distant stroma, particularly in younger and male patients and patients with hypopharynx carcinomas. Moreover, higher infiltration of M2-like TAMs turned out to be an independent prognostic factor of poorer survival even exceeding the impact of the p16-status and the tumor site.
Discussion
In summary, our data provide a strong rationale to target M2-like TAMs to improve success of immune-modulatory treatments and survival of patients suffering from p16-negative HNSCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, University of Heidelberg, Medical Faculty of Heidelberg, Heidelberg, Germany.
- Department of Otorhinolaryngology, Head and Neck Surgery, Klinikum Kassel, Kassel, Germany.
- Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Medical Faculty of Heidelberg, Heidelberg, Germany.
- Institute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
- Hamamatsu Tissue Imaging and Analysis Center, BioQuant, University of Heidelberg, Heidelberg, Germany.
Zitieren
APA
Yılmaz Topçuoğlu, M. S., Krum, D., Warta, R., Lotsch, C., Kütük, O., Mogler, C., Grabe, N., Schuler, P. J., Dyckhoff, G., & Herold-Mende, C. (2026). Spatial distribution and prognostic value of tumor-associated macrophages in head and neck squamous cell carcinomas. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1806162
Vancouver
Yılmaz Topçuoğlu MS, Krum D, Warta R, Lotsch C, Kütük O, Mogler C, et al. Spatial distribution and prognostic value of tumor-associated macrophages in head and neck squamous cell carcinomas. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1806162
BibTeX
@article{YlmazTopuolu2026,
author = {Yılmaz Topçuoğlu, Miray-Su and Krum, David and Warta, Rolf and Lotsch, Catharina and Kütük, Oktay and Mogler, Carolin and Grabe, Niels and Schuler, Patrick J and Dyckhoff, Gerhard and Herold-Mende, Christel},
title = {Spatial distribution and prognostic value of tumor-associated macrophages in head and neck squamous cell carcinomas},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1806162}
}
EUVIMED